38 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
beneficially owned by the shareholder unless noted otherwise, subject to community property laws where applicable.
Shares beneficially owned
Name
8-K
EX-99.1
VRNA
Verona Pharma Plc
29 Feb 24
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:08am
ended December 31, 2023 (full year 2022: $68.7 million).
Conference Call and Webcast Information
Verona Pharma will host an investment community
8-K
EX-99.1
3jms3z l3waslzn
2 Nov 23
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:24am
8-K
EX-99.1
w14g3f
3 Aug 23
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:11am
8-K
EX-99.1
3a13nd9zjyh1aahgv
9 May 23
Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
6:13am
8-K
EX-99.1
1qcr pp9wr465
9 Nov 22
Verona Pharma Reports Third Quarter 2022 Financial Results and Provides Corporate Update
6:35am
8-K
EX-99.1
tdo6e0svtai32x8wj
9 Aug 22
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:17am
8-K
EX-99.1
davtp2nwt47z81
3 May 22
Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
6:11am
8-K
EX-99.1
no70s8
3 Mar 22
Verona Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
6:06am
8-K
EX-99.1
mfu8vzo
9 Nov 21
Verona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update
9:00am
8-K
EX-99.1
vo7l2fw
5 Aug 21
Verona Pharma Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:21pm
8-K
EX-99.1
wgrjfiv6soqf5 izz0z
29 Apr 21
Verona Pharma Reports First Quarter 2021 Financial Results and Provides Corporate Update
6:46am
POS AM
fqojxhlz 6soep
19 Mar 21
Prospectus update (post-effective amendment)
4:56pm
DEF 14A
cs0kh4g
19 Mar 21
Definitive proxy
4:02pm
10-K
EX-10.20
uvf q44p1lpt
25 Feb 21
Annual report
8:29am